Northera

Active Ingredient(s): Droxidopa
FDA Approved: * February 18, 2014
Pharm Company: * CHELSEA THERAPEUTICS INC
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Northera Overview

Droxidopa (INN; trade name Northera; also known as L-DOPS, L-threo-dihydroxyphenylserine, L-threo-DOPS and SM-5688) is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitter norepinephrine (noradrenaline).[1] Unlike norepinephrine, droxidopa is capable of crossing the protective blood–brain barrier (BBB).[1] Contents 1 Medical uses 2 Side effects 3 Pharmacology 4 Chemistry 5 History 5.1 Clinical trials 6 Research 7 Reference...

Read more Northera Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Droxidopa

Recent Northera Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Droxidopa
  • Capsule: 100mg, 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Northera: (6 results)

Sorted by National Drug Code
  • 67386-820 Northera 100 mg Oral Capsule by Lundbeck LLC
  • 67386-821 Northera 200 mg Oral Capsule by Lundbeck LLC
  • 67386-822 Northera 300 mg Oral Capsule by Lundbeck LLC
  • 76320-100 Northera 100 mg/1 Oral Capsule by Chelsea Therapeutics Inc
  • 76320-200 Northera 200 mg/1 Oral Capsule by Chelsea Therapeutics Inc
  • 76320-300 Northera 300 mg/1 Oral Capsule by Chelsea Therapeutics Inc

Other drugs which contain Droxidopa or a similar ingredient: (1 result)